<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">An Bras Dermatol</journal-id>
      <journal-id journal-id-type="iso-abbrev">An Bras Dermatol</journal-id>
      <journal-id journal-id-type="publisher-id">abd</journal-id>
      <journal-title-group>
        <journal-title>Anais Brasileiros de Dermatologia</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0365-0596</issn>
      <issn pub-type="epub">1806-4841</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Dermatologia</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">28225964</article-id>
      <article-id pub-id-type="pmc">5312186</article-id>
      <article-id pub-id-type="doi">10.1590/abd1806-4841.20175009</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Penile squamous cell carcinoma: a review of the literature and case
report treated with Mohs micrographic surgery<xref ref-type="fn" rid="fn1">*</xref>
</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Marchionne</surname>
            <given-names>Elizabeth</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Perez</surname>
            <given-names>Caroline</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hui</surname>
            <given-names>Andrea</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Khachemoune</surname>
            <given-names>Amor</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">2</xref>
          <xref ref-type="corresp" rid="c1"/>
        </contrib>
      </contrib-group>
      <aff id="aff1"><label>1</label>School of medicine - University of Nevada - Reno, United
States</aff>
      <aff id="aff2"><label>2</label>Department of Dermatology - State University of New York
- Downstate and Veterans Affairs Medical Center - Brooklyn (NY), United States</aff>
      <author-notes>
        <corresp id="c1">Mailing address: Amor Khachemoune, Veterans Affairs Medical Center
800, Poly Place Brooklyn, NY 11209. Email: <email>Amorkh@gmail.com</email></corresp>
      </author-notes>
      <pub-date pub-type="epub-ppub">
        <season>Jan-Feb</season>
        <year>2017</year>
      </pub-date>
      <!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' -->
      <pub-date pub-type="ppub">
        <season>Jan-Feb</season>
        <year>2017</year>
      </pub-date>
      <volume>92</volume>
      <issue>1</issue>
      <fpage>95</fpage>
      <lpage>99</lpage>
      <history>
        <date date-type="received">
          <day>04</day>
          <month>8</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>28</day>
          <month>10</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9;2017 by Anais Brasileiros de
Dermatologia</copyright-statement>
        <copyright-year>2017</copyright-year>
        <copyright-holder>Anais Brasileiros de Dermatologia</copyright-holder>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">
          <license-p>This is an Open Access article distributed under the terms of the
Creative Commons Attribution Non-Commercial License which permits
unrestricted non-commercial use, distribution, and reproduction in any
medium provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>The majority of penile carcinoma is squamous cell carcinoma. Although uncommon in
the United States, it represents a larger proportion of cancers in the
underdeveloped world. Invasive squamous cell carcinoma may arise from precursor
lesions or <italic>de novo</italic> , and has been associated with lack of
circumcision and HPV infection. Early diagnosis is imperative as lymphatic
spread is associated with a poor prognosis. Radical surgical treatment is no
longer the mainstay, and penile sparing treatments now are often used, including
Mohs micrographic surgery. Therapeutic decisions should be made with regard to
the size and location of the tumor, as well as the functional desires of the
patient. It is critical for the dermatologist to be familiar with the
evaluation, grading/staging, and treatment advances of penile squamous cell
carcinoma. Herein, we present a review of the literature regarding penile
squamous cell carcinoma, as well as a case report of invasive squamous cell
carcinoma treated with Mohs micrographic surgery.</p>
      </abstract>
      <kwd-group>
        <kwd>Carcinoma, squamous cell</kwd>
        <kwd>Mohs surgery</kwd>
        <kwd>Penile neoplasms</kwd>
        <kwd>Penis</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>INTRODUCTION</title>
      <p>Penile cancer is a rare diagnosis in the United States and other developed nations.
In the United States in 2015, the American Cancer Society predicted 1,820 new cases
with 310 penile cancer deaths.<sup><xref rid="r1" ref-type="bibr">1</xref></sup>
However, the disease is more common in developing countries, where it may represent
up to 10% of cancers in males.<sup><xref rid="r2" ref-type="bibr">2</xref>,<xref rid="r3" ref-type="bibr">3</xref>,<xref rid="r4" ref-type="bibr">4</xref></sup> The majority of penile cancer is squamous cell carcinoma
(SCC).<sup><xref rid="r5" ref-type="bibr">5</xref></sup></p>
      <p>The pathogenesis of penile cancer is not entirely known. SCC may evolve from penile
intraepithelial neoplasia (PIN) or arise <italic>de novo</italic> .<sup><xref rid="r4" ref-type="bibr">4</xref></sup> Penile SCC has been associated with
high-risk HPV infections, most commonly strains 16 and 18. The mechanism through
which HPV leads to penile cancer is most likely mediated through viral oncogenes E6
and E7, which are actively transcribed by HPV-infected cells. Viral oncogene E6
targets p53 and viral oncogene E7 targets RB1; both p53 and RB1 are tumor suppressor
genes, which are negative regulators of cell proliferation. When these genes are
transformed, this may lead to unchecked proliferation and subsequent development of
malignancy.<sup><xref rid="r3" ref-type="bibr">3</xref></sup> HPV-DNA has
been found in only 22-72% of penile SCC, but has been identified in the vast
majority of PIN (70-100%).<sup><xref rid="r3" ref-type="bibr">3</xref></sup> This
discordance between the presence of HPV-DNA in SCC versus PIN suggests an HPV
independent and dependent etiology for the development of SCC.<sup><xref rid="r4" ref-type="bibr">4</xref></sup></p>
      <p>The prevalence of genital HPV-DNA in men is 1.3% to 72.9%, with a mean of &gt;20%
reported by most studies.<sup><xref rid="r6" ref-type="bibr">6</xref></sup> In
several cohort studies, it is estimated that most HPV infections in men clear in
less than 12 months, with a median of 5.9 to 7.5 months.<sup><xref rid="r7" ref-type="bibr">7</xref>,<xref rid="r8" ref-type="bibr">8</xref></sup> Increasing
age and fewer numbers of female partners are positively correlated with a greater
probability of clearing an HPV infection.<sup><xref rid="r8" ref-type="bibr">8</xref></sup> The development of the quadrivalent HPV vaccine to high-risk
strains 6, 11, 16, and 18, has been shown to significantly reduce HPV-associated
genital disease in men, including genital warts, with an efficacy of
89.4%.<sup><xref rid="r9" ref-type="bibr">9</xref></sup> The use of the HPV
vaccine in males has the potential to significantly reduce the incidence of penile
cancer, among other disfiguring genital lesions such as condylomas and genital
warts.</p>
      <p>Penile SCC occurs almost exclusively in uncircumcised men.<sup><xref rid="r3" ref-type="bibr">3</xref></sup> Neonatal circumcision is implicated as strongly
protective against penile cancer.<sup><xref rid="r10" ref-type="bibr">10</xref>,<xref rid="r11" ref-type="bibr">11</xref></sup> Proposed
etiological factors associated with an intact foreskin are smegma and phimosis.
Smegma is a product of desquamating epithelial cells and bacterial byproducts found
between the glans penis and foreskin.<sup><xref rid="r11" ref-type="bibr">11</xref></sup> Smegma-induced chronic inflammation may predispose to the
development of phimosis as well as SCC.<sup><xref rid="r4" ref-type="bibr">4</xref></sup> Phimosis, the inability to retract the foreskin over the glans,
has been found in 25-60% of patients with penile cancer.<sup><xref rid="r3" ref-type="bibr">3</xref>,<xref rid="r4" ref-type="bibr">4</xref></sup> It is
associated with an increased incidence of infection as well as dysplastic changes of
the preputial sac.<sup><xref rid="r12" ref-type="bibr">12</xref></sup> Further,
uncircumcised men have been found to be at an increased risk of HPV infection when
compared to their circumcised counterparts.<sup><xref rid="r13" ref-type="bibr">13</xref></sup> Additional risk factors associated with the development of
penile SCC include smoking, HIV infection, poor genital hygiene, previous injury to
the penis, chronic balanitis, lichen sclerosis et atrophicus, and psoralen plus
ultraviolet A treatment to the area.<sup><xref rid="r3" ref-type="bibr">3</xref>,<xref rid="r4" ref-type="bibr">4</xref>,<xref rid="r14" ref-type="bibr">14</xref></sup></p>
      <p>Penile SCC most commonly presents between the ages of 50 and 70 years.<sup><xref rid="r3" ref-type="bibr">3</xref></sup> The majority of lesions are found on
the glans (48%), followed by the prepuce (21%), both glans and prepuce (15%),
coronal sulcus (6%), and shaft (&lt;2%).<sup><xref rid="r3" ref-type="bibr">3</xref></sup> Clinical presentation is variable. It may present as a small
area of induration and erythema or a large ulcerating and infiltrative lesion. As
the disease progresses, there may be associated itching, bleeding, discharge, foul
odor, and pain.<sup><xref rid="r3" ref-type="bibr">3</xref></sup> Presentation may
be delayed secondary to psychological factors, with an estimated 15 to 60% of
patients postponing presentation for at least one year.<sup><xref rid="r3" ref-type="bibr">3</xref>,<xref rid="r4" ref-type="bibr">4</xref></sup> Despite
this, most men (66%) initially present with localized disease.<sup><xref rid="r4" ref-type="bibr">4</xref></sup> Assessment of lymphatic spread with
palpation of inguinal lymph nodes is an essential component of the initial physical
exam. Lymphatic spread usually occurs in a predictable course, first to the
superficial and deep inguinal nodes, followed by the pelvic, and then periaortic
nodes.<sup><xref rid="r15" ref-type="bibr">15</xref></sup> Distant
metastases are generally uncommon (1-10%) and occur late in the disease.<sup><xref rid="r3" ref-type="bibr">3</xref>,<xref rid="r15" ref-type="bibr">15</xref></sup></p>
      <p>Differential diagnostic considerations of penile SCC include premalignant and
malignant lesions, infections, and inflammatory conditions. Neoplastic lesions such
as erythroplasia of Queyrat, Bowen's disease or Bowenoid papulosis should be
considered.<sup><xref rid="r4" ref-type="bibr">4</xref></sup> Condyloma
acuminata may resemble SCC, especially the verrucous variant. Ulceration and
lymphadenopathy may raise concern for the chancre of a primary syphilis infection or
the chancroid of Haemophilus ducreyi. Additionally, the psoriatic scales and plaques
of genital psoriasis and violaceous lesions of lichen planus may appear clinically
similar to SCC.<sup><xref rid="r14" ref-type="bibr">14</xref></sup></p>
      <p>Penile SCC can be divided into several subtypes. The most common subtypes include
usual SCC (48-65%), basaloid carcinoma (4-10%), warty carcinoma (7-10%), verrucous
carcinoma (3-8%), papillary carcinoma (5-15%), and mixed carcinomas
(9-10%).<sup><xref rid="r16" ref-type="bibr">16</xref></sup> Each subtype
has distinct histologic features. Histopathologic analysis is used to grade the
tumor, which is then assigned on a spectrum based on cellular differentiation (<xref ref-type="table" rid="t1">Chart 1</xref>).<sup><xref rid="r14" ref-type="bibr">14</xref>,<xref rid="r16" ref-type="bibr">16</xref>,<xref rid="r17" ref-type="bibr">17</xref></sup> Staging is performed using the TNM penile cancer
system developed by the American Joint Committee on Cancer (<xref ref-type="table" rid="t2">Chart 2</xref>).<sup><xref rid="r17" ref-type="bibr">17</xref></sup>
Staging is based on depth of tumor invasion, nodal involvement, and distant
metastases (<xref ref-type="table" rid="t3">Chart 3</xref>).<sup><xref rid="r17" ref-type="bibr">17</xref></sup></p>
      <table-wrap id="t1" orientation="portrait" position="float">
        <label>Chart 1</label>
        <caption>
          <p>Histopathological grading of penile SCC</p>
        </caption>
        <table frame="box" rules="groups">
          <colgroup span="1">
            <col width="50%" span="1"/>
            <col width="50%" span="1"/>
          </colgroup>
          <thead>
            <tr>
              <th align="left" colspan="2" rowspan="1">Pathological Grading (G)</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td align="left" rowspan="1" colspan="1">GX</td>
              <td align="left" rowspan="1" colspan="1">Grade cannot be assessed</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">G1</td>
              <td align="left" rowspan="1" colspan="1">Well differentiated</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">G2</td>
              <td align="left" rowspan="1" colspan="1">Moderately differentiated</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">G3</td>
              <td align="left" rowspan="1" colspan="1">Poorly differentiated</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">G4</td>
              <td align="left" rowspan="1" colspan="1">Undifferentiated</td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <fn id="TFN1">
            <p>Reproduced with the permission of the American Joint Committee on Cancer
(AJCC), Chicago, Illinois. The original source for this material is the
AJCC Cancer Staging Manual, Seventh Edition (2010) published by Springer
Science and Business Media LLC, <ext-link ext-link-type="uri" xlink:href="http://www.springer.com">www.springer.com</ext-link>.</p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
      <table-wrap id="t2" orientation="portrait" position="float">
        <label>Chart 2</label>
        <caption>
          <p>American Joint Committee on Cancer TMN classification for penile cancer</p>
        </caption>
        <table frame="box" rules="groups">
          <colgroup span="1">
            <col width="10%" span="1"/>
            <col width="90%" span="1"/>
          </colgroup>
          <thead>
            <tr>
              <th align="left" colspan="2" rowspan="1">Primary Tumor (T)</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td align="left" rowspan="1" colspan="1">TX</td>
              <td align="left" rowspan="1" colspan="1">Primary tumor cannot be assessed</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">T0</td>
              <td align="left" rowspan="1" colspan="1">No evidence of primary tumor</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Tis</td>
              <td align="left" rowspan="1" colspan="1">Carcinoma in situ</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Ta</td>
              <td align="left" rowspan="1" colspan="1">Noninvasive verrucous carcinoma*</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">T1a</td>
              <td align="left" rowspan="1" colspan="1">Tumor invades subepithelial connective tissue
without<break/> lymph vascular invasion and is not poorly
differentiated<break/> (i.e., grade 3-4)</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">T1b</td>
              <td align="left" rowspan="1" colspan="1">Tumor invades subepithelial connective tissue with
lymph<break/> vascular invasion and is poorly differentiated</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">T2</td>
              <td align="left" rowspan="1" colspan="1">Tumor invades corpus spongiosum or cavernosum</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">T3</td>
              <td align="left" rowspan="1" colspan="1">Tumor invades urethra</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">T4</td>
              <td align="left" rowspan="1" colspan="1">Tumor invades other adjacent structures</td>
            </tr>
            <tr>
              <td align="left" colspan="2" rowspan="1">* Note: Broad pushing penetration
(invasion) is permitted; destructive<break/> invasion is against
this diagnosis.</td>
            </tr>
            <tr style="border-bottom-width:thin;border-bottom-style:solid">
              <td align="left" colspan="2" rowspan="1">Regional Lymph Nodes (N)</td>
            </tr>
            <tr>
              <td align="left" colspan="2" rowspan="1">Clinical Stage Definition*</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">cNX</td>
              <td align="left" rowspan="1" colspan="1">Regional lymph nodes cannot be assessed</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">cN0</td>
              <td align="left" rowspan="1" colspan="1">No palpable or visibly enlarged inguinal lymph
nodes</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">cN1</td>
              <td align="left" rowspan="1" colspan="1">Palpable mobile unilateral inguinal lymph node</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">cN2</td>
              <td align="left" rowspan="1" colspan="1">Palpable mobile multiple or bilateral inguinal lymph
nodes</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">cN3</td>
              <td align="left" rowspan="1" colspan="1">Palpable fixed inguinal lymph nodal mass or pelvic
lymphadenopathy<break/> unilateral or bilateral</td>
            </tr>
            <tr>
              <td align="left" colspan="2" rowspan="1">* Note: Clinical stage definition based on
palpation, imaging</td>
            </tr>
            <tr style="border-bottom-width:thin;border-bottom-style:solid">
              <td align="left" colspan="2" rowspan="1">Pathologic Stage Definition*</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">pNX</td>
              <td align="left" rowspan="1" colspan="1">Regional lymph nodes cannot be assessed</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">pN0</td>
              <td align="left" rowspan="1" colspan="1">No regional lymph node metastasis</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">pN1</td>
              <td align="left" rowspan="1" colspan="1">Metastasis in a single inguinal lymph node</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">pN2</td>
              <td align="left" rowspan="1" colspan="1">Metastasis in multiple or bilateral inguinal lymph
nodes</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">pN3</td>
              <td align="left" rowspan="1" colspan="1">Extranodal extension of lymph node metastasis or
pelvic<break/> lymph node(s) unilateral or bilateral</td>
            </tr>
            <tr>
              <td align="left" colspan="2" rowspan="1">*Note: Pathologic stage definition based on
biopsy or surgical<break/> excision.</td>
            </tr>
            <tr style="border-bottom-width:thin;border-bottom-style:solid">
              <td align="left" colspan="2" rowspan="1">Distant Metastasis (M)</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">M0</td>
              <td align="left" rowspan="1" colspan="1">No distant metastasis</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">M1</td>
              <td align="left" rowspan="1" colspan="1">Distant metastasis*</td>
            </tr>
            <tr>
              <td align="left" colspan="2" rowspan="1">*Note: Lymph node metastasis outside of the
true pelvis in addition<break/> to visceral or bone sites.</td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <fn id="TFN2">
            <p>Reproduced with the permission of the American Joint Committee on Cancer
(AJCC), Chicago, Illinois. The original source for this material is the
AJCC Cancer Staging Manual, Seventh Edition (2010) published by Springer
Science and Business Media LLC, <ext-link ext-link-type="uri" xlink:href="http://www.springer.com">www.springer.com</ext-link>.</p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
      <table-wrap id="t3" orientation="portrait" position="float">
        <label>Chart 3</label>
        <caption>
          <p>American Joint Committee on Cancer penile cancer staging</p>
        </caption>
        <table frame="box" rules="groups">
          <colgroup span="1">
            <col width="25%" span="1"/>
            <col width="25%" span="1"/>
            <col width="25%" span="1"/>
            <col width="25%" span="1"/>
          </colgroup>
          <thead>
            <tr>
              <th align="left" colspan="4" rowspan="1">Anatomic Stage/Prognostic Groups</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td align="left" rowspan="1" colspan="1">Stage 0</td>
              <td align="left" rowspan="1" colspan="1">Tis</td>
              <td align="left" rowspan="1" colspan="1">N0</td>
              <td align="left" rowspan="1" colspan="1">M0</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">&#xA0;</td>
              <td align="left" rowspan="1" colspan="1">Ta</td>
              <td align="left" rowspan="1" colspan="1">N0</td>
              <td align="left" rowspan="1" colspan="1">M0</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Stage I</td>
              <td align="left" rowspan="1" colspan="1">T1a</td>
              <td align="left" rowspan="1" colspan="1">N0</td>
              <td align="left" rowspan="1" colspan="1">M0</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Stage II</td>
              <td align="left" rowspan="1" colspan="1">T1b</td>
              <td align="left" rowspan="1" colspan="1">N0</td>
              <td align="left" rowspan="1" colspan="1">M0</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">&#xA0;</td>
              <td align="left" rowspan="1" colspan="1">T2</td>
              <td align="left" rowspan="1" colspan="1">N0</td>
              <td align="left" rowspan="1" colspan="1">M0</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">&#xA0;</td>
              <td align="left" rowspan="1" colspan="1">T3</td>
              <td align="left" rowspan="1" colspan="1">N0</td>
              <td align="left" rowspan="1" colspan="1">M0</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Stage IIIa</td>
              <td align="left" rowspan="1" colspan="1">T1-3</td>
              <td align="left" rowspan="1" colspan="1">N1</td>
              <td align="left" rowspan="1" colspan="1">M0</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Stage IIIb</td>
              <td align="left" rowspan="1" colspan="1">T1-3</td>
              <td align="left" rowspan="1" colspan="1">N2</td>
              <td align="left" rowspan="1" colspan="1">M0</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Stage IV</td>
              <td align="left" rowspan="1" colspan="1">T4</td>
              <td align="left" rowspan="1" colspan="1">Any N</td>
              <td align="left" rowspan="1" colspan="1">M0</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">&#xA0;</td>
              <td align="left" rowspan="1" colspan="1">Any T</td>
              <td align="left" rowspan="1" colspan="1">N3</td>
              <td align="left" rowspan="1" colspan="1">M0</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">&#xA0;</td>
              <td align="left" rowspan="1" colspan="1">Any T</td>
              <td align="left" rowspan="1" colspan="1">Any N</td>
              <td align="left" rowspan="1" colspan="1">M1</td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <fn id="TFN3">
            <p>Reproduced with the permission of the American Joint Committee on Cancer
(AJCC), Chicago, Illinois. The original source for this material is the
AJCC Cancer Staging Manual, Seventh Edition (2010) published by Springer
Science and Business Media LLC, <ext-link ext-link-type="uri" xlink:href="http://www.springer.com">www.springer.com</ext-link>.</p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
      <p>Surgical decisions should be made with regard to the size and location of the tumor,
as well as the functional desires of the patient. For patients with PIN, topical
imiquimod or 5-fluorouracil, circumcision and local excision, and laser ablative
therapy could be used as penile preserving techniques.<sup><xref rid="r14" ref-type="bibr">14</xref></sup> When treating patients with well- to
moderately-differentiated T1 SCC tumors, penile sparing surgery should be
utilized.<sup><xref rid="r14" ref-type="bibr">14</xref></sup> In these stage
I tumors, wide local excision using 2 cm margins has been traditionally used;
however, smaller 5 to 10 mm margins have shown low recurrence rates.<sup><xref rid="r14" ref-type="bibr">14</xref></sup> Mohs micrographic surgery (MMS) is
becoming increasingly popular and has the ability to provide superior aesthetic
results with preservation of normal surrounding tissue.<sup><xref rid="r15" ref-type="bibr">15</xref>,<xref rid="r18" ref-type="bibr">18</xref>,<xref rid="r19" ref-type="bibr">19</xref></sup></p>
      <p>A great advantage of using MMS is removal of the tumor with complete visualization to
ensure negative margins.<sup><xref rid="r18" ref-type="bibr">18</xref>,<xref rid="r19" ref-type="bibr">19</xref></sup> For penile SCC, MMS is most
successful in smaller tumors with lower grade.<sup><xref rid="r18" ref-type="bibr">18</xref></sup> If urethral involvement is present, MMS should be
discouraged.<sup><xref rid="r19" ref-type="bibr">19</xref></sup> Patients
with tumors staged II and above are usually not candidates for penile sparing
therapy due to larger tumor size and further depth of invasion.<sup><xref rid="r14" ref-type="bibr">14</xref>,<xref rid="r15" ref-type="bibr">15</xref></sup> Partial or total penectomy should be considered in these
patients. Concern should be taken for preservation of urination and sexual
function.<sup><xref rid="r20" ref-type="bibr">20</xref></sup> Radiation and
chemotherapy could be used as adjuvant therapy or in cases of palliation.<sup><xref rid="r15" ref-type="bibr">15</xref></sup></p>
      <p>Evaluation of lymphatic spread is critical and guidelines are still
emerging.<sup><xref rid="r5" ref-type="bibr">5</xref></sup> About 28-64% of
patients will present with palpable inguinal nodes.<sup><xref rid="r21" ref-type="bibr">21</xref></sup> However, of these, 47-85% will have metastatic
disease, with the remainder of nodal enlargement secondary to
inflammation.<sup><xref rid="r4" ref-type="bibr">4</xref>,<xref rid="r21" ref-type="bibr">21</xref></sup> Even in patients without palpable
nodes, an estimated 25% will still have micrometastatic disease.<sup><xref rid="r14" ref-type="bibr">14</xref></sup> Inguinal lymph node dissection is
a diagnostic and potentially curative procedure.<sup><xref rid="r14" ref-type="bibr">14</xref>,<xref rid="r22" ref-type="bibr">22</xref></sup> However, due to
potential complications, it is preferred to only perform this procedure in patients
at a high risk for metastasis.<sup><xref rid="r15" ref-type="bibr">15</xref>,<xref rid="r22" ref-type="bibr">22</xref></sup> Techniques such as MRI, PET scan,
fine needle aspiration, and dynamic sentinel node biopsy may precede an inguinal
lymph node dissection.<sup><xref rid="r15" ref-type="bibr">15</xref></sup> Minimally
invasive techniques such as laparoscopic or robotic-assisted inguinal
lymphadenectomy are evolving.<sup><xref rid="r22" ref-type="bibr">22</xref>,<xref rid="r23" ref-type="bibr">23</xref></sup> A multidisciplinary treatment team
involving medical oncology, radiation oncology, urology, and psychiatry in addition
to dermatology may be warranted.<sup><xref rid="r15" ref-type="bibr">15</xref>,<xref rid="r24" ref-type="bibr">24</xref></sup></p>
      <p>Prognosis is good for localized disease. The most important prognostic factor is the
extent of nodal metastasis.<sup><xref rid="r15" ref-type="bibr">15</xref>,<xref rid="r21" ref-type="bibr">21</xref></sup> The 5-year cancer specific
survival of a primary SCC with no inguinal metastasis is 85-100%, one positive node
is 79 to 89%, bilateral or multiple nodal metastasis is 17 to 60%, and metastasis to
pelvic nodes is 0 to 17%.<sup><xref rid="r21" ref-type="bibr">21</xref></sup>
Prognosis with extranodal metastasis is poor.<sup><xref rid="r21" ref-type="bibr">21</xref></sup></p>
    </sec>
    <sec>
      <title>CASE REPORT</title>
      <p>A 60-year-old men presented for evaluation of a penile lesion present for one year.
The patient denied any associated pain, bleeding, odor, discharge, or dysuria. There
were no recent changes to the lesion. The patient denied history of sexually
transmitted infections and reported being in a monogamous relationship with his
girlfriend for 25 years. He denied any erectile dysfunction. The patient was
otherwise healthy and family history was noncontributory. Physical exam was
significant for a 1.5 x 1.5 cm erythematous ulcerated plaque on the inner foreskin 3
cm from the urethral tip and 1 cm from the coronal sulcus (<xref ref-type="fig" rid="f1">Figure 1</xref>). Inguinal lymphadenopathy was not appreciated on
palpation, however exam was limited due to the presence of bilateral inguinal
hernias.</p>
      <p>
        <fig id="f1" orientation="portrait" position="float">
          <label>Figure 1</label>
          <caption>
            <p>1.5 cm x 1.5 cm ulcerated and erythematous lesion on the penis</p>
          </caption>
          <graphic xlink:href="abd-92-01-0095-gf01"/>
        </fig>
      </p>
      <p>A shave biopsy was obtained and revealed invasive squamous cell carcinoma, moderately
differentiated (<xref ref-type="fig" rid="f2">Figure 2</xref>). The decision was
made to proceed with Mohs micrographic surgery (MMS) and to refer the patient to
urology for evaluation of inguinal nodes following MMS. Imaging to determine if
enlarged nodes were present was not performed preoperatively.</p>
      <p>
        <fig id="f2" orientation="portrait" position="float">
          <label>Figure 2</label>
          <caption>
            <p>Squamous cell carcinoma, moderately differentiated. Atypical cells extend
into the deep dermis. (Hematoxylin &amp; eosin x10)</p>
          </caption>
          <graphic xlink:href="abd-92-01-0095-gf02"/>
        </fig>
      </p>
      <p>The tumor bulk was excised, followed by one stage of MMS with excision of the borders
as a horizontal layer, 2-3 mm in thickness. The tissue was mapped, frozen, cut, and
stained with toluidine blue. Microscopic evaluation confirmed the tumor was
completely excised with no further disease in the deep outer borders. The lesion
invaded into the deep dermis with no invasion into adjacent structures. The defect
was repaired in the office using linear closure (<xref ref-type="fig" rid="f3">Figure 3</xref>).</p>
      <p>
        <fig id="f3" orientation="portrait" position="float">
          <label>Figure 3</label>
          <caption>
            <p>Linear closure of the defect, immediately post-operative</p>
          </caption>
          <graphic xlink:href="abd-92-01-0095-gf03"/>
        </fig>
      </p>
      <p>The consultant urologist concluded that the patient's inguinal hernias limited nodal
evaluation and recommended hernia repair prior to further assessment. The patient
was seen by general surgery for evaluation, however he refused further
interventions.</p>
      <p>The patient was followed for over one year with no evidence of recurrence of the
lesion and no functional concerns.</p>
      <p>Squamous cell carcinoma of the penis is a rare diagnosis. Therapeutic decisions
should be made with regard to the size and location of the tumor, as well as with
consideration to the functional desires of the patient. Mohs micrographic surgery is
an excellent alternative for patients with tumors of low grade and stage.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn fn-type="COI-statement">
        <p>Conflict of Interest: None</p>
      </fn>
      <fn fn-type="supported-by">
        <p>Financial Support: None</p>
      </fn>
      <fn fn-type="other" id="fn1">
        <label>*</label>
        <p>Study conducted at the Downstate and Veterans Affairs Medical Center - Brooklyn
(NY), United States.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>References</title>
      <ref id="r1">
        <label>1</label>
        <element-citation publication-type="book">
          <source>Cancer Facts and Figures 2015</source>
          <year>2015</year>
          <publisher-loc>Atlanta, Ga</publisher-loc>
          <publisher-name>American Cancer Society</publisher-name>
        </element-citation>
      </ref>
      <ref id="r2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pow-Sang</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Ferreira</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Pow-Sang</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Nardi</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Destefano</surname>
              <given-names>V</given-names>
            </name>
          </person-group>
          <article-title>Epidemiology and natural history of penile cancer</article-title>
          <source>Urology</source>
          <year>2010</year>
          <volume>76</volume>
          <fpage>S2</fpage>
          <lpage>S6</lpage>
          <pub-id pub-id-type="pmid">20691882</pub-id>
        </element-citation>
      </ref>
      <ref id="r3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Barnholtz-sloan</surname>
              <given-names>JS</given-names>
            </name>
            <name>
              <surname>Maldonado</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Pow-sang</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Giuliano</surname>
              <given-names>AR</given-names>
            </name>
            <name>
              <surname>Guiliano</surname>
              <given-names>AR</given-names>
            </name>
          </person-group>
          <article-title>Incidence trends in primary malignant penile
cancer</article-title>
          <source>Urol Oncol</source>
          <year>2007</year>
          <volume>25</volume>
          <fpage>361</fpage>
          <lpage>367</lpage>
          <pub-id pub-id-type="pmid">17826651</pub-id>
        </element-citation>
      </ref>
      <ref id="r4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Brady</surname>
              <given-names>KL</given-names>
            </name>
            <name>
              <surname>Mercurio</surname>
              <given-names>MG</given-names>
            </name>
            <name>
              <surname>Brown</surname>
              <given-names>MD</given-names>
            </name>
          </person-group>
          <article-title>Malignant tumors of the penis</article-title>
          <source>Dermatol Surg</source>
          <year>2013</year>
          <volume>39</volume>
          <fpage>527</fpage>
          <lpage>547</lpage>
          <pub-id pub-id-type="pmid">23164051</pub-id>
        </element-citation>
      </ref>
      <ref id="r5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Burt</surname>
              <given-names>LM</given-names>
            </name>
            <name>
              <surname>Shrieve</surname>
              <given-names>DC</given-names>
            </name>
            <name>
              <surname>Tward</surname>
              <given-names>JD</given-names>
            </name>
          </person-group>
          <article-title>Stage presentation, care patterns, and treatment outcomes for
squamous cell carcinoma of the penis</article-title>
          <source>Int J Radiat Oncol Biol Phys</source>
          <year>2014</year>
          <volume>88</volume>
          <fpage>94</fpage>
          <lpage>100</lpage>
          <pub-id pub-id-type="pmid">24119832</pub-id>
        </element-citation>
      </ref>
      <ref id="r6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dunne</surname>
              <given-names>EF</given-names>
            </name>
            <name>
              <surname>Nielson</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Stone</surname>
              <given-names>KM</given-names>
            </name>
            <name>
              <surname>Markowitz</surname>
              <given-names>LE</given-names>
            </name>
            <name>
              <surname>Giuliano</surname>
              <given-names>AR</given-names>
            </name>
          </person-group>
          <article-title>Prevalence of HPV infection among men: a systematic review of the
literature</article-title>
          <source>J Infect Dis</source>
          <year>2006</year>
          <volume>194</volume>
          <fpage>1044</fpage>
          <lpage>1057</lpage>
          <pub-id pub-id-type="pmid">16991079</pub-id>
        </element-citation>
      </ref>
      <ref id="r7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lu</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Nielson</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Flores</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Abrahamsen</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Papenfuss</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Factors associated with acquisition and clearance of human
papillomavirus infection in a cohort of US men: a prospective
study</article-title>
          <source>J Infect Dis</source>
          <year>2009</year>
          <volume>199</volume>
          <fpage>362</fpage>
          <lpage>371</lpage>
          <pub-id pub-id-type="pmid">19133808</pub-id>
        </element-citation>
      </ref>
      <ref id="r8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Giuliano</surname>
              <given-names>AR</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Fulp</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Villa</surname>
              <given-names>LL</given-names>
            </name>
            <name>
              <surname>Lazcano</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Papenfuss</surname>
              <given-names>MR</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Incidence and clearance of genital human papillomavirus infection
in men (HIM): a cohort study</article-title>
          <source>Lancet</source>
          <year>2011</year>
          <volume>377</volume>
          <fpage>932</fpage>
          <lpage>940</lpage>
          <pub-id pub-id-type="pmid">21367446</pub-id>
        </element-citation>
      </ref>
      <ref id="r9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Giuliano</surname>
              <given-names>AR</given-names>
            </name>
            <name>
              <surname>Palefsky</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Goldstone</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Moreira Jr</surname>
              <given-names>ED</given-names>
            </name>
            <name>
              <surname>Penny</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>Aranda</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Efficacy of quadrivalent HPV vaccine against HPV Infection and
disease in males</article-title>
          <source>N Engl J Med</source>
          <year>2011</year>
          <volume>364</volume>
          <fpage>401</fpage>
          <lpage>411</lpage>
          <pub-id pub-id-type="pmid">21288094</pub-id>
        </element-citation>
      </ref>
      <ref id="r10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Larke</surname>
              <given-names>NL</given-names>
            </name>
            <name>
              <surname>Thomas</surname>
              <given-names>SL</given-names>
            </name>
            <name>
              <surname>dos Santos Silva</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Weiss</surname>
              <given-names>HA</given-names>
            </name>
          </person-group>
          <article-title>Male circumcision and penile c&#xE2;ncer: a systematic review
and meta-analysis</article-title>
          <source>Cancer Causes Control</source>
          <year>2011</year>
          <volume>22</volume>
          <fpage>1097</fpage>
          <lpage>1110</lpage>
          <pub-id pub-id-type="pmid">21695385</pub-id>
        </element-citation>
      </ref>
      <ref id="r11">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Morris</surname>
              <given-names>BJ</given-names>
            </name>
            <name>
              <surname>Gray</surname>
              <given-names>RH</given-names>
            </name>
            <name>
              <surname>Castellsague</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Bosch</surname>
              <given-names>FX</given-names>
            </name>
            <name>
              <surname>Halperin</surname>
              <given-names>DT</given-names>
            </name>
            <name>
              <surname>Waskett</surname>
              <given-names>JH</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The Strong Protective Effect of Circumcision against Cancer of
the Penis</article-title>
          <source>Adv Urol</source>
          <year>2011</year>
          <volume>2011</volume>
          <fpage>812368</fpage>
          <lpage>812368</lpage>
          <pub-id pub-id-type="pmid">21687572</pub-id>
        </element-citation>
      </ref>
      <ref id="r12">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Reddy</surname>
              <given-names>CR</given-names>
            </name>
            <name>
              <surname>Devendranath</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Pratap</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Carcinoma of penis--role of phimosis</article-title>
          <source>Urology</source>
          <year>1984</year>
          <volume>24</volume>
          <fpage>85</fpage>
          <lpage>88</lpage>
          <pub-id pub-id-type="pmid">6740858</pub-id>
        </element-citation>
      </ref>
      <ref id="r13">
        <label>13</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Castellsagu&#xE9;</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Bosch</surname>
              <given-names>FX</given-names>
            </name>
            <name>
              <surname>Mu&#xF1;oz</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Meijer</surname>
              <given-names>CJ</given-names>
            </name>
            <name>
              <surname>Shah</surname>
              <given-names>KV</given-names>
            </name>
            <name>
              <surname>de Sanjose</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Male circumcision, penile human papillomavirus infection, and
cervical cancer in female partners</article-title>
          <source>N Engl J Med</source>
          <year>2002</year>
          <volume>346</volume>
          <fpage>1105</fpage>
          <lpage>1112</lpage>
          <pub-id pub-id-type="pmid">11948269</pub-id>
        </element-citation>
      </ref>
      <ref id="r14">
        <label>14</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Spiess</surname>
              <given-names>PE</given-names>
            </name>
            <name>
              <surname>Horenblas</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Pagliaro</surname>
              <given-names>LC</given-names>
            </name>
            <name>
              <surname>Biagioli</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Crook</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Clark</surname>
              <given-names>PE</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Current concepts in penile cancer</article-title>
          <source>J Natl Compr Canc Netw</source>
          <year>2013</year>
          <volume>11</volume>
          <fpage>617</fpage>
          <lpage>624</lpage>
          <pub-id pub-id-type="pmid">23667210</pub-id>
        </element-citation>
      </ref>
      <ref id="r15">
        <label>15</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>McDougal</surname>
              <given-names>WS</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Efstathiou</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Harisinghani</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>CL</given-names>
            </name>
          </person-group>
          <article-title>Case records of the Massachusetts General Hospital. Case 2-2014.
A 44-year-old man with a lesion on the penis</article-title>
          <source>N Engl J Med</source>
          <year>2014</year>
          <volume>370</volume>
          <fpage>263</fpage>
          <lpage>271</lpage>
          <pub-id pub-id-type="pmid">24428472</pub-id>
        </element-citation>
      </ref>
      <ref id="r16">
        <label>16</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chaux</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Cubilla</surname>
              <given-names>AL</given-names>
            </name>
          </person-group>
          <article-title>Advances in the pathology of penile carcinomas</article-title>
          <source>Hum Pathol</source>
          <year>2012</year>
          <volume>43</volume>
          <fpage>771</fpage>
          <lpage>789</lpage>
          <pub-id pub-id-type="pmid">22595011</pub-id>
        </element-citation>
      </ref>
      <ref id="r17">
        <label>17</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Edge</surname>
              <given-names>SB</given-names>
            </name>
            <name>
              <surname>Byrd</surname>
              <given-names>DR</given-names>
            </name>
            <name>
              <surname>Compton</surname>
              <given-names>CC</given-names>
            </name>
            <name>
              <surname>Fritz</surname>
              <given-names>AG</given-names>
            </name>
            <name>
              <surname>Greene</surname>
              <given-names>FL</given-names>
            </name>
            <name>
              <surname>Trotti</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <source>AJCC Cancer Staging Manual</source>
          <year>2010</year>
          <edition>7th ed</edition>
          <publisher-loc>NY</publisher-loc>
          <publisher-name>Springer</publisher-name>
        </element-citation>
      </ref>
      <ref id="r18">
        <label>18</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shindel</surname>
              <given-names>AW</given-names>
            </name>
            <name>
              <surname>Mann</surname>
              <given-names>MW</given-names>
            </name>
            <name>
              <surname>Lev</surname>
              <given-names>RY</given-names>
            </name>
            <name>
              <surname>Sengelmann</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Petersen</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Hruza</surname>
              <given-names>GJ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Mohs micrographic surgery for penile c&#xE2;ncer: management
and long-term followup</article-title>
          <source>J Urol</source>
          <year>2007</year>
          <volume>178</volume>
          <fpage>1980</fpage>
          <lpage>1985</lpage>
          <pub-id pub-id-type="pmid">17869306</pub-id>
        </element-citation>
      </ref>
      <ref id="r19">
        <label>19</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wells</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Taylor</surname>
              <given-names>RS</given-names>
            </name>
          </person-group>
          <article-title>Mohs micrographic surgery for penoscrotal
malignancy</article-title>
          <source>Urol Clin North Am</source>
          <year>2010</year>
          <volume>37</volume>
          <fpage>403</fpage>
          <lpage>409</lpage>
          <pub-id pub-id-type="pmid">20674695</pub-id>
        </element-citation>
      </ref>
      <ref id="r20">
        <label>20</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kieffer</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Djajadiningrat</surname>
              <given-names>RS</given-names>
            </name>
            <name>
              <surname>van Muilekom</surname>
              <given-names>EA</given-names>
            </name>
            <name>
              <surname>Graafland</surname>
              <given-names>NM</given-names>
            </name>
            <name>
              <surname>Horenblas</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Aaronson</surname>
              <given-names>NK</given-names>
            </name>
          </person-group>
          <article-title>Quality of life in patients treated for penile
cancer</article-title>
          <source>J Urol</source>
          <year>2014</year>
          <volume>192</volume>
          <fpage>1105</fpage>
          <lpage>1110</lpage>
          <pub-id pub-id-type="pmid">24747092</pub-id>
        </element-citation>
      </ref>
      <ref id="r21">
        <label>21</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ficarra</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Akduman</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Bouchot</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Palou</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Tobias-Machado</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Prognostic factors in penile cancer</article-title>
          <source>Urology</source>
          <year>2010</year>
          <volume>76</volume>
          <fpage>S66</fpage>
          <lpage>S73</lpage>
          <pub-id pub-id-type="pmid">20691887</pub-id>
        </element-citation>
      </ref>
      <ref id="r22">
        <label>22</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kharadjian</surname>
              <given-names>TB</given-names>
            </name>
            <name>
              <surname>Matin</surname>
              <given-names>SF</given-names>
            </name>
            <name>
              <surname>Pettaway</surname>
              <given-names>CA</given-names>
            </name>
          </person-group>
          <article-title>Early experience of robotic-assisted inguinal lymphadenectomy:
review of surgical outcomes relative to alternative
approaches</article-title>
          <source>Curr Urol Rep</source>
          <year>2014</year>
          <volume>15</volume>
          <fpage>412</fpage>
          <lpage>412</lpage>
          <pub-id pub-id-type="pmid">24756453</pub-id>
        </element-citation>
      </ref>
      <ref id="r23">
        <label>23</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Matin</surname>
              <given-names>SF</given-names>
            </name>
            <name>
              <surname>Cormier</surname>
              <given-names>JN</given-names>
            </name>
            <name>
              <surname>Ward</surname>
              <given-names>JF</given-names>
            </name>
            <name>
              <surname>Pisters</surname>
              <given-names>LL</given-names>
            </name>
            <name>
              <surname>Wood</surname>
              <given-names>CG</given-names>
            </name>
            <name>
              <surname>Dinney</surname>
              <given-names>CP</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Phase 1 prospective evaluation of the oncological adequacy of
robotic assisted videoendoscopic inguinal lymphadenectomy in patients with
penile carcinoma</article-title>
          <source>BJU Int</source>
          <year>2013</year>
          <volume>111</volume>
          <fpage>1068</fpage>
          <lpage>1074</lpage>
          <pub-id pub-id-type="pmid">23551693</pub-id>
        </element-citation>
      </ref>
      <ref id="r24">
        <label>24</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yeung</surname>
              <given-names>LL</given-names>
            </name>
            <name>
              <surname>Brandes</surname>
              <given-names>SB</given-names>
            </name>
          </person-group>
          <article-title>Dynamic sentinel lymph node biopsy as the new paradigm for the
management of penile cancer</article-title>
          <source>Urol Oncol</source>
          <year>2013</year>
          <volume>31</volume>
          <fpage>693</fpage>
          <lpage>696</lpage>
          <pub-id pub-id-type="pmid">23158262</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
